SRF
SRF Celebrates Women’s History Month
We are proud to present the many women of SENS Research Foundation, including our researchers, executive, and administrative teams. SRF is currently 100% female-led internally, with an all-women Senior Staff Team and Chairperson on the Board of Directors. While it does take the entire community of SRF staff and supporters to move our mission forward, this month we are thrilled to highlight the women who continue to drive our progress in longevity research.
SENS Research Foundation & Underdog Pharmaceuticals jointly awarded $252,000 NIA research grant
The National Institute on Aging (NIA) division of the National Institutes of Health (NIH) has awarded a grant to advance research on Engineered Cyclodextrins targeting toxic oxidized cholesterol to eradicate atherosclerosis — the cause of most heart attacks and strokes.
Former SRF V.P. of Research and current Underdog Co-founder Matthew O’Connor, Ph.D. and current SRF V.P. of Research Alexandra Stolzing, Ph.D., are the Principal Investigators.
SRF’s researchers presenting our work at Indian biosciences conferences
Our VP of Research Dr. Alex Stolzing and Senescence Immunology Research Group Lead Dr. Amit Sharma will be presenting at conferences in India this week, including at the 35th Annual Conference of Aging Interventions, organized by the Society of Neurochemistry, India (SNCI), and the Darwin International Conference.
British Daily Mirror featured an interview with SENS Research Foundation’s Science Writer Michael Rae about the world’s richest men taking on the longevity challenge
As part of the widespread media coverage of the launch of Altos Labs and the rising tide of investment into rejuvenation biotechnology, a recent article in a British daily featured an interview with SENS Research Foundation’s Science Writer Michael Rae on Altos Labs, cellular reprogramming, and its place within the SENS platform of rejuvenation biotechnologies and the push toward a future of indefinite medical maintenance of healthy, youthful life.
Longevity Science Foundation’s $1 billion, 10 year distribution shows shift in attitudes since SRF inception
SRF is elated at the announcement in Longevity Technology of a fund that will distribute more than $1 billion over a ten year period specifically “to research, institutions and projects advancing healthy human longevity and extending the healthy human lifespan to more than 120 years.”
Few may remember the environment in which SRF began, in which interest in longevity research and significant extension of human life was far outside the mainstream. This financial commitment is another hard-fought victory in shifting attitudes towards fighting aging.
Congratulations to our long-time collaborators: the Buck Institute, Judith Campisi and team for the new NIH grant.
Buck scientists will identify and characterize senescent cells – recognized as a driver of age-related disease – in human ovaries, breast tissue and skeletal muscle. “We are thrilled that the NIH is investing in studying cellular senescence in humans…” said Campisi.
NIA Reports Senolytics Show Potential to Protect Against Coronavirus in Older Mice
The NIA reports: “Cellular senescence, an aging mechanism in which cells lose normal function, may contribute to a worse response in human cells to COVID-19 and in older mice to a similar coronavirus — but a class of drug known as senolytics decreased adverse responses and increased survival for the mice. The preclinical findings from a study funded in part by NIA were recently published in Science.”
This is also the focus of one of SRF’s projects that is working on selectively removing senescent cells and reversing the damage caused by them to rejuvenate the immune system.
SENS Research Foundation wishes you Happy International Longevity Day and Longevity Month!
The United Nations General Assembly voted to establish October 1st as the ‘International Day of Older Persons’ as recorded in Resolution 45/106. The holiday was observed for the first time on October 1st, 1991.
Following this tradition, longevity research activists from around the world call this day and the month of October; International Longevity Day and International Longevity Month.
Annual Mitochondrial Disease Awareness Week 2021
SENS Research Foundation joins the Mitochondrial Medicine Society and MITOAction.org during the third week of September in raising awareness for the Annual Mitochondrial Disease Awareness Week.
Mitochondrial function declines with age, and these dysfunctional mitochondria adversely contribute to several metabolic and neuromuscular diseases. The mitoSENS team is working tirelessly to help discover the science to reverse and/or prevent damage to mitochondrial DNA.
